Physician
Urology
Dr. Fredrick S. Leach, MD
|
|
Give Review
Doctor Fredrick S. Leach, MD works in the field of Urology. He went to medical school at Stanford University School of Medicine. Stanford University School of Medicine is a one of the best medicals schools. Stanford University School of Medicine has a rank of 2 in research and a 25 in primary care He received awards:"Regional Top Doctor". Fredrick S. Leach, MD is a published MD. He published 32 publications, including: 'Evaluation of the FHIT gene in colorectal cancers.' Fredrick Leach accepts Medicare payments and is registered with Medicare.gov.
Publications
- Adenocarcinoma in ectopic prostatic tissue at dome of bladder: a case report of a patient with urothelial carcinoma of the bladder and adenocarcinoma of the prostate.
- Mismatch repair expression in testicular cancer predicts recurrence and survival.
- CDC4 gene expression as potential biomarker for targeted therapy in prostate cancer.
- Tissue microarray analysis of hMSH2 expression predicts outcome in men with prostate cancer.
- Prostate specific antigen as a clinical biomarker for prostate cancer: what's the take home message?
- Microsatellite instability and loss of heterozygosity have distinct prognostic value for testicular germ cell tumor recurrence.
- Mismatch repair gene expression and genetic instability in testicular germ cell tumor.
- Linking human genetics with molecular medicine: will hereditary renal cancer play a major role?
- Decreased expression of bone morphogenetic protein (BMP) receptor type II correlates with insensitivity to BMP-6 in human renal cell carcinoma cells.
- Detection of mismatch repair gene expression in urologic malignancies.
- Microsatellite instability and prostate cancer: clinical and pathological implications.
- Mismatch repair gene mutations in renal cell carcinoma.
- Clinicopathologic implications of hMSH2 gene expression and microsatellite instability in prostate cancer.
- Differential expression of the mismatch repair gene hMSH2 in malignant prostate tissue is associated with cancer recurrence.
- Regulation of cytomegalovirus late-gene expression: differential use of three start sites in the transcriptional activation of ICP36 gene expression.
- Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers.
- p53 Mutation and MDM2 amplification in human soft tissue sarcomas.
- Monoallelic mutation analysis (MAMA) for identifying germline mutations.
- Rare presentation of actinomycosis as an abdominal mass: report of a case.
- Evaluation of the FHIT gene in colorectal cancers.
- Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer.
- Detection of genetic loss in tumors by representational difference analysis.
- Mismatch repair genes on chromosomes 2p and 3p account for a major share of hereditary nonpolyposis colorectal cancer families evaluable by linkage.
- Mutations in DNA mismatch repair genes are not responsible for microsatellite instability in most sporadic endometrial carcinomas.
- Raloxifene, a selective estrogen receptor modulator, induces apoptosis in androgen-responsive human prostate cancer cell line LNCaP through an androgen-independent pat...
- Expression of the human mismatch repair gene hMSH2 in normal and neoplastic tissues.
- [Immunohistochemical and molecular analyis of mismatch repair genes in germ cell tumors].
- Targeting prostate-specific membrane antigen in cancer therapy: can molecular medicine be brought to the surface?
- Sharpening the tools for prostate cancer detection in the PSA era: what's the point?
- Expression of the human mismatch repair gene hMSH2: a potential marker for urothelial malignancy.
- The mismatch repair gene hMSH2 is mutated in the prostate cancer cell line LNCaP.
Schools
Stanford University School Of Medicine
The Johns Hopkins Hospital
University Of Texas Southwestern Medical Center
Southern Methodist University
Procedures Preformed
- Adrenalectomy
- Anterior and-or Posterior Bladder Repair
- Anterior and-or Posterior Bladder Surgery
- Bladder Cancer Surgery
- View All
Doctors Specialties
- Urology
Accepted Insurances
- Accepts most major Health Plans. Please contact our office for details.
- Blue Choice HMO
- Blue Advantage
- Blue Choice
- Blue Cross Blue Shield of Illinois HMO
- Blue Cross Blue Shield of Illinois PPO
- Blue Care Elect PPO
- Blue Cross Accord
- Blue Cross Blue Shield of New Mexico PPO
- Blue Options PPO
- Network S
- Behavioral Health
- Choice Fund
- Choice Fund PPO
- Cigna EPO
- Cigna Network
- Commercial EPO
- Commercial HMO
- Commercial PPO
- Dental PPO
- Indemnity EPO
- Medicare Access MCR
- Medicare Advantage HMO
- Medicare Advantage MCR
- Network Open Access
- Open Access
- Open Access Plus PPO
- Select Network HMO
- Select Network POS
- Select Network PPO
- Medicare for Railroad Workers MCR
- Medicare MCR
Awards
- Regional Top Doctor
Education
-
University of Texas Southwestern Medical School -
Johns Hopkins University -
Stanford University School of Medicine
Drug Facts
| NPI NUMBER | 1871542050 | |
| NPPES Provider LastName | LEACH | |
| NPPES Provider FirstName | FREDRICK | |
| NPPES Provider ZIPCode | 750931637 | |
| NPPES Provider State | TX | |
| Specialty Description | Urology | |
| Total Claim Count | 435.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 18.0 | |
| Percent Opioid Claims | 4.14 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1871542050 |
| Last Name Of The Provider | LEACH |
| First Name Of The Provider | FREDRICK |
| View All |
Similar Doctors
|
Dr. Mark L. Allen, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alan L. Freeman, MD |
|
Dr. William L. Mulchin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nancy Y. Kim, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Keith T. Kadesky, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Frances B. Herbert, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ralph J. Posch, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vince J. Rogenes, MD
This Doctor is OpenDoctor Recommended.
|